Kazia Therapeutics: Funding, Investors & Team (Sep 2026)
Kazia Therapeutics is a biotechnology company specializing in oncology, creating groundbreaking anti-cancer medications. The company partners with top researchers, doctors, and investors globally.
Kazia Therapeutics has raised $36.7M across 4 funding rounds on record, the most recent an undisclosed round of $32.9M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kazia Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Kazia Therapeutics Funding Rounds
Kazia Therapeutics raised $1.3M in an undisclosed round announced in Dec 2023.
1.1 years later, an undisclosed round of $1.2M was announced in Jan 2025.
7 months later, an undisclosed round of $1.3M was announced in Aug 2025.
4 months later, an undisclosed round of $32.9M was announced in Dec 2025.
Kazia Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Kazia Therapeutics Funding Compared to Other Biotechnology Startups
Kazia Therapeutics' latest round of $32.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kazia Therapeutics in Biotechnology and Hornsby
Companies Similar to Kazia Therapeutics
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Kazia Therapeutics Funding FAQs
What does Kazia Therapeutics do?
Kazia Therapeutics is a biotechnology company specializing in oncology, creating groundbreaking anti-cancer medications. The company partners with top researchers, doctors, and investors globally.
How much funding has Kazia Therapeutics raised?
Kazia Therapeutics has raised $36.7M across 4 rounds on record. The most recent is an undisclosed round of $32.9M announced in Dec 2025.
When did Kazia Therapeutics last raise funding?
Kazia Therapeutics' most recent funding round on record is an undisclosed round of $32.9M, announced in Dec 2025.
Who founded Kazia Therapeutics?
FundedIQ lists Graham Kelly (Founder) at Kazia Therapeutics.
Where is Kazia Therapeutics headquartered?
Kazia Therapeutics is based in Hornsby, New South Wales, Australia.
How many employees does Kazia Therapeutics have?
Kazia Therapeutics is in the 11-50 employee band.
How does Kazia Therapeutics' funding compare to other Biotechnology startups?
Kazia Therapeutics' latest round of $32.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Kazia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kazia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.